Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.22 - $8.26 $52,200 - $82,600
10,000 Added 37.74%
36,500 $29.6 Million
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $161,650 - $275,865
26,500 New
26,500 $34 Million
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $751,506 - $978,562
123,400 Added 979.37%
136,000 $242,000
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $159,384 - $320,508
-34,800 Reduced 73.42%
12,600 $54,000
Q2 2022

Aug 12, 2022

SELL
$7.06 - $23.63 $235,804 - $789,242
-33,400 Reduced 41.34%
47,400 $291,000
Q1 2022

May 12, 2022

BUY
$21.6 - $27.79 $866,160 - $1.11 Million
40,100 Added 98.53%
80,800 $101,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $501,400 - $632,418
21,800 Added 115.34%
40,700 $26,000
Q2 2021

Aug 11, 2021

BUY
$27.43 - $32.7 $32,916 - $39,240
1,200 Added 6.78%
18,900 $14,000
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $589,812 - $948,888
-27,600 Reduced 60.93%
17,700 $21,000
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $489,920 - $675,840
32,000 Added 240.6%
45,300 $14,000
Q1 2020

May 08, 2020

SELL
$12.98 - $30.25 $2.53 Million - $5.91 Million
-195,300 Reduced 93.62%
13,300 $143,000
Q4 2019

Feb 11, 2020

SELL
$18.89 - $31.89 $368,355 - $621,855
-19,500 Reduced 8.55%
208,600 $4,000
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $258,912 - $318,184
12,400 Added 5.75%
228,100 $71,000
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $4.48 Million - $5.78 Million
-218,400 Reduced 50.31%
215,700 $66,000
Q1 2019

May 10, 2019

SELL
$20.23 - $26.29 $3.02 Million - $3.93 Million
-149,300 Reduced 25.59%
434,100 $234,000
Q4 2018

Feb 12, 2019

BUY
$17.64 - $28.32 $9.35 Million - $15 Million
529,800 Added 988.43%
583,400 $2.83 Million
Q3 2018

Nov 09, 2018

BUY
$20.64 - $25.67 $1.11 Million - $1.38 Million
53,600 New
53,600 $44,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.